Breaking News
US Oil Blockade of Venezuela Pushes Cuba Into Economic Collapse
Gold and Silver Surge to New Record Highs, What's Going On?
Silver And Copper Are Both Flashing The Same Signal -- And That Is Setting The Stage...
I Spoke At Turning Point USA - FULL SPEECH
Top Tech News
Perfect Aircrete, Kitchen Ingredients.
Futuristic pixel-raising display lets you feel what's onscreen
Cutting-Edge Facility Generates Pure Water and Hydrogen Fuel from Seawater for Mere Pennies
This tiny dev board is packed with features for ambitious makers
Scientists Discover Gel to Regrow Tooth Enamel
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Galactic Brain: US firm plans space-based data centers, power grid to challenge China
A microbial cleanup for glyphosate just earned a patent. Here's why that matters
Japan Breaks Internet Speed Record with 5 Million Times Faster Data Transfer
Advanced Propulsion Resources Part 1 of 2
Nanotech platform Carries mRNA Directly to Target Cells
The groundbreaking method may prove useful in treating myriad malignancies, inflammatory diseases and rare genetic disorders.
Lipid nanoparticles (LNP) were used to deliver modified messenger RNA to treat inflammatory bowel diseases and other diseases.
Prof. Dan Peer, Molecular Cell Biology at TAU's Faculty of Life Sciences, led the research for the new study.
Over the past few years, lipid carriers encapsulating messenger RNAs (mRNAs) have been shown to be extremely useful in altering the protein expressions for a host of diseases. But directing this information to specific cells has remained a major challenge.
"In our new research, we utilized mRNA-loaded carriers — nanovehicles carrying a set of genetic instructions via a biological platform called ASSET — to target the genetic instructions of an anti-inflammatory protein in immune cells," says Prof. Peer.